小结
定义
病史和体格检查
关键诊断因素
- 存在的危险因素
- 头痛
- 风湿性多肌痛
- 四肢跛行
- 其他颅动脉异常
- 视力丧失
- 下颌运动障碍
- 颞浅动脉触痛、增厚,或结节感
- 颞动脉搏动消失
- 眼底镜检查异常
其他诊断因素
- 全身症状
- 神经系统症状
- 咳嗽、咽痛、声嘶
- 听诊杂音
- 血压不对称
- 肩膀触痛
- 肩部和髋部活动范围受限
- 手腕和膝关节肿胀
危险因素
- 年龄≥50 岁
- 女性
- 遗传因素
- 吸烟
- 动脉粥样硬化
- 环境因素
诊断性检查
首要检查
- 红细胞沉降率 (ESR)
- C 反应蛋白 (CRP)
- 全血细胞计数(FBC)
- 肝功能检查 (LFT)
- 颞动脉活检
- 颞动脉超声
需考虑的检查
- 无创血管成像
新兴检查
- 头部至大腿中部的 FDG-PET 扫描
- 上肢动脉的超声扫描
治疗流程
疑似巨细胞动脉炎
确诊巨细胞动脉炎
撰稿人
作者
Kenneth J. Warrington, MD
Professor of Medicine
Mayo Clinic College of Medicine
Rochester
MN
利益声明
KJW’s employer receives payments from Eli Lilly and Kiniksa for his role as investigator in giant cell arteritis clinical trials. KJW has conducted consulting work for Sanofi, and received compensation from Roche/Genentech for lecturing. KJW is an author of a number of references cited in this topic.
鸣谢
Dr Kenneth J. Warrington wishes to gratefully acknowledge Dr Eric L. Matteson, a previous contributor to this topic.
利益声明
ELM’s employer has received payments from Bristol Meyers Squibb and GlaxoSmithKline for his role as investigator in giant cell arteritis clinical trials; from Novartis for his role in polymyalgia rheumatica clinical trials; and from GlaxoSmithKline for his role as an advisory consultant. ELM is an author and editor for Up To Date and Paradigm, as well as an author of a number of references cited in this topic.
同行评议者
Anisha B. Dua, MD, MPH
Associate Professor
Northwestern University Feinberg School of Medicine
Chicago
IL
利益声明
ABD declares they have paid consultancies from Amgen, Abbvie, Novartis, GSK and Sanofi. ABD is on the board of directors for the Vasculitis Foundation.
Kuntal Chakravarty, FRCP (London), FRCP (Glasgow), FRCP (Ireland), FACP (USA), FACR (USA)
Consultant Rheumatologist
BHRT University Hospital
Queen’s Hospital
Romford
UK
利益声明
KC declares that he has no competing interests.
鉴别诊断
- 风湿性多肌痛 (PMR)
- 实体器官肿瘤和血液恶性肿瘤
- 大动脉炎 (TA)
更多 鉴别诊断指南
- 美国风湿病学会/欧洲抗风湿病联盟的巨细胞动脉炎分类标准
- 糖皮质激素性骨质疏松症的预防和治疗指南
更多 指南患者教育信息
巨细胞动脉炎
更多 患者教育信息Videos
静脉穿刺和抽血的动画演示
更多 操作视频- 登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明